LDHB and non-small cell lung carcinoma: Developmental pluripotency-associated 4 (DPPA4) was found to be a poor prognostic factor in NSCLC patients due to the enhancement of glycolytic metabolism via increased activity of LDHB, HK2, and GLUT4 (Li L. et al., 2019).